Open AccessAre Clinicians Contributing to Excess African American COVID-19 Deaths? Unbeknownst to Them, They May Be
Author(s) -
Adam J. Milam,
Debra Furr-Holden,
Jennifer Edwards-Johnson,
Birgete Webb,
John W. Patton,
Nnayereugo C. Ezekwemba,
Lekiesha Porter,
TomMario Davis,
Marius Chukwurah,
Antonio J. Webb,
Kevin M. Simon,
Geden Franck,
Joshua R. Anthony,
Gerald Onuoha,
Italo M. Brown,
James Taylor Carson,
Brent Stephens
Publication year - 2020
Publication title -
health equity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.826
H-Index - 9
ISSN - 2473-1242
DOI - 10.1089/heq.2020.0015
Subject(s) - covid-19 , health equity , pandemic , multitude , equity (law) , psychology , demography , medicine , gerontology , disease , political science , public health , sociology , infectious disease (medical specialty) , pathology , law , outbreak
African Americans are overrepresented among reported coronavirus disease 2019 (COVID-19) cases and deaths. There are a multitude of factors that may explain the African American disparity in COVID-19 outcomes, including higher rates of comorbidities. While individual-level factors predictably contribute to disparate COVID-19 outcomes, systematic and structural factors have not yet been reported. It stands to reason that implicit biases may fuel the racial disparity in COVID-19 outcomes. To address this racial disparity, we must apply a health equity lens and disaggregate data explicitly for African Americans, as well as other populations at risk for biased treatment in the health-care system.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom